A large Canadian study suggests that nirsevimab, a long-acting monoclonal antibody used to prevent respiratory syncytial ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants. The US Food and Drug Administration ...

As fall approaches, so does respiratory syncytial virus or RSV season. This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance for ...

If your patient is pregnant or older than 60 years and due for a respiratory syncytial virus (RSV) shot, now’s the time to act. A major new review highlighted the vaccine’s impact and safety, ...

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in infants and children younger than 2 years. The most severe and life-threatening cases typically affect ...

RSV cases and hospitalizations in California are rising this winter season. Infants and older adults face higher risk of severe RSV infection. Vaccination and hygiene help prevent spread. Respiratory ...

Although cold and flu season is winding down in the United States, respiratory syncytial virus (RSV) activity still remains high in many parts of the country. RSV is a highly contagious virus that can ...

Flu and Covid, including a new variant called BA.3.2, nicknamed “cicada,” are still circulating, along with several other respiratory illnesses and a nasty stomach bug.

RSV vaccines showed initial high effectiveness, but protection decreased over 18 months, especially in immunocompromised individuals. The study used VHA data to evaluate vaccine effectiveness in ...

With respiratory virus season in full swing in California, you may be feeling under the weather. Cases of the flu and respiratory syncytial virus are on the rise in California, the California ...